ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Cumberland Pharmaceuticals, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 0.20% and Operating profit at 9.27% over the last 5 years
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -44.94%, its profits have risen by 61.3%
3
Below par performance in long term as well as near term
- Along with generating -44.94% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Cumberland Pharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Cumberland Pharmaceuticals, Inc.
-44.94%
0.98
101.64%
S&P 500
14.9%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.20%
EBIT Growth (5y)
9.27%
EBIT to Interest (avg)
-6.60
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.33
Sales to Capital Employed (avg)
0.99
Tax Ratio
0.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
27.63%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.75
EV to EBIT
-12.48
EV to EBITDA
12.76
EV to Capital Employed
2.19
EV to Sales
0.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-17.52%
ROE (Latest)
-11.40%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET PROFIT(HY)
Higher at USD -2.63 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 2.96 times
RAW MATERIAL COST(Y)
Fallen by -3.33% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -18.98 %
-11What is not working for the Company
PRE-TAX PROFIT(Q)
At USD -1.93 MM has Fallen at -149.28%
NET PROFIT(Q)
At USD -1.93 MM has Fallen at -151.21%
CASH AND EQV(HY)
Lowest at USD 31.28 MM
NET SALES(Q)
Lowest at USD 8.29 MM
Here's what is working for Cumberland Pharmaceuticals, Inc.
Inventory Turnover Ratio
Highest at 2.96 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debt-Equity Ratio
Lowest at -18.98 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -3.33% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Cumberland Pharmaceuticals, Inc.
Net Sales
At USD 8.29 MM has Fallen at -21.16%
over average net sales of the previous four periods of USD 10.52 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -1.93 MM has Fallen at -149.28%
over average net sales of the previous four periods of USD -0.78 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -1.93 MM has Fallen at -151.21%
over average net sales of the previous four periods of USD -0.77 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Net Sales
Lowest at USD 8.29 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Cash and Eqv
Lowest at USD 31.28 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
